Physician profile
Eric A Jentoft
NPI 1508077405
$15,217.09
in general payments reported to CMS, 2019-2025
11 companies · $84.20 in 2025
The $84.20 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $130 · 2020: $45.01 · 2021: $15K · 2022: $64.48 · 2023: $15.38 · 2024: $11.01 · 2025: $84.20.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $110.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $14,801.92 | 2021 | |
| Abbvie INC. | $210.07 | 2019-2022 | |
| Sage Therapeutics, LLC | $62.01 | 2025 | Zurzuvae |
| Pfizer INC. | $28.78 | 2022-2023 | |
| Davol INC. | $26.32 | 2021 | |
| Smith+Nephew, INC. | $22.19 | 2025 | Pico 14 |
| Merck Sharp & Dohme LLC | $14.19 | 2022 | |
| Amag Pharmaceuticals, INC. | $13.72 | 2019 | |
| Daiichi Sankyo INC. | $13.68 | 2019 | |
| Olympus America INC. | $13.20 | 2021 | |
| Organon LLC | $11.01 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Jentoft listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.